Full Breakdown
Englewood Health to Join RWJBarnabas Health: A New Chapter for New Jersey's Healthcare Landscape
1/5/2026, 8:12:38 PM
Overview of the Partnership
Englewood Health has entered into a definitive agreement to become part of RWJBarnabas Health, marking a significant shift in New Jersey's healthcare landscape. This partnership aims to enhance healthcare access and services across Bergen, Hudson, and Passaic counties. The agreement is pending approval from state and federal regulators, with expectations that the approval process will extend throughout 2026.
Context of the Agreement
This announcement follows a failed merger attempt between Englewood Health and Hackensack Meridian Health three years prior, which was blocked by the Federal Trade Commission (FTC) due to concerns over monopolization in Bergen County. Englewood Health has remained one of the few independent hospitals in New Jersey amid a trend of consolidations in the healthcare sector, with RWJBarnabas Health already operating 14 hospitals statewide.
Goals and Benefits of the Partnership
The collaboration is designed to leverage the strengths of both organizations. RWJBarnabas Health President and CEO Mark Manigan emphasized that the partnership is not a rescue mission, as Englewood Hospital is performing well, recently receiving the Leapfrog Group’s “Top Hospital Award” for patient safety and quality of care. Englewood Health President and CEO Warren Geller stated that the timing is ideal for such a partnership, as both institutions are not acting out of necessity but rather a desire to enhance services.
The partnership is expected to lead to significant capital investments in Englewood, including the expansion of operating rooms, renovations to the neonatal intensive care unit, and improvements in ambulatory care. Englewood patients will also gain access to advanced services, such as those offered by the Rutgers Cancer Institute, New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center.
Criticism and Concerns
Despite the optimistic outlook, some experts have raised concerns about the implications of hospital mergers. Historical data suggests that such consolidations can lead to increased prices and reduced patient satisfaction due to diminished competition. Critics argue that the merger could potentially limit choices for patients in the region.
Official Statements
Mark Manigan stated, “We look to build upon this history together to enhance access to world-class academic medicine and cutting-edge cancer treatment.” Warren Geller echoed this sentiment, saying, “This transaction will ensure Englewood Health’s ability to deliver world-class care to the communities we serve in a broader way, with greater resources and more cutting-edge technologies.”
What's Next
As Englewood Health and RWJBarnabas Health await regulatory approval, both organizations will continue to operate independently. The outcome of this partnership could reshape the healthcare delivery model in North Jersey, leaving only three major independent hospitals in the region if the merger proceeds.
Conclusion
The agreement between Englewood Health and RWJBarnabas Health represents a pivotal moment for healthcare in New Jersey, with potential benefits for patient care and service expansion, tempered by concerns regarding market competition and patient choice. The coming months will be crucial as stakeholders await regulatory decisions that will determine the future of this partnership.
